Short Interest in Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Drops By 99.0%

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a drop of 99.0% from the February 29th total of 9,900 shares. Based on an average trading volume of 37,700 shares, the days-to-cover ratio is presently 0.0 days.

Mydecine Innovations Group Stock Performance

Shares of MYCOF remained flat at $0.01 during trading hours on Thursday. 1,124 shares of the company were exchanged, compared to its average volume of 26,468. The company’s 50-day simple moving average is $0.01 and its 200-day simple moving average is $0.05. Mydecine Innovations Group has a 52 week low of $0.00 and a 52 week high of $0.66.

Mydecine Innovations Group Company Profile

Mydecine Innovations Group Inc, a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004.